Organization (Academic)
University of New England
ClinicalTrials.gov lists University of New England as lead sponsor of 12 trials.
Search trials, drugs, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Trials started per year with this organization as sponsor or collaborator, 1990 onward. The series also counts trials where the organization is a collaborator; the lead-sponsor trial count does not.
2026 is partial: 0 registered with a 2026 start date. The dashed outline is the pace from the 0 registered with a start date through September, planned starts included, not adjusted; not a forecast. No forecast is made for this organization: it averages 0.6 trial starts a year over the five years to September, under the 5 a year the method needs.
Logo University of New England, via Wikimedia Commons, Public domain. Shown to identify the organization; it may be a registered trademark.
This page covers University of New England: 12 lead-sponsored trials and 2 legal-entity registrations.
Disease areas (23)
Shown in this order: most trials first.
| Disease area | Trials |
|---|---|
| Pain | 3 |
| Acquired Immunodeficiency Syndrome | 2 |
| HIV Infections | 2 |
| Muscle Weakness | 2 |
| Agnosia | 1 |
Showing 5 of 23 disease areas.
Trials by start year as sponsor or collaborator (10)
Shown in this order: most recent first. 2026 is partial: trials registered with a 2026 start date so far, not a full year.
Show the table of trials by start year as sponsor or collaborator
| Year | Trials started |
|---|---|
| 2025 | 1 |
| 2022 | 1 |
| 2021 | 5 |
| 2018 | 2 |
| 2017 | 1 |
| 2016 | 3 |
| 2015 | 1 |
| 2014 | 1 |
| 2007 | 2 |
| 2006 | 1 |
Recruitment duration, a model prediction: 1 trial still running at the 2026-10-09 snapshot, fewer than the 5 needed for a median. Source: ClinicalTrials.gov / AACT (CTTI), public domain.
Sponsor delivery record (1)
Enrollment hit target: the share of this sponsor's lead-sponsored trials whose actual enrollment reached the planned enrollment. On time: the share whose actual primary completion date was no later than the planned date. Each share counts only trials where we observed an estimated figure before the actual one, and n is that number of trials. Below 5 trials the count is shown as a fraction, not a percentage.
| Enrollment | Timeline |
|---|---|
| 1 of 3 hit target (n=3) | 1 of 4 on time (n=4) |
Journals published in (35)
Shown in this order: most published in first.
| Journal | Publications |
|---|---|
| Journal of manipulative and physiological therapeutics | 5 |
| BMC medical informatics and decision making | 2 |
| European journal of applied physiology | 2 |
| International journal of sports physical therapy | 2 |
| Manual therapy | 2 |
Showing 5 of 35 journals.
US granted patents (1)
Patents are not classified by disease area in the source, so this is the organization's overall portfolio, not a split by disease.
| US patents granted | Granted in the last 5 years | Most recent grant |
|---|---|---|
| 9 | 1 | 2024-11-26 |
Financing and grant events (48)
Shown in this order: most recent first.
| Date | Round type | Amount (USD) | Source |
|---|---|---|---|
| 2025-09-19 | NIH grant | 1,117,237 | Reporter |
| 2025-08-11 | NIH grant | 355,000 | Reporter |
| 2025-08-06 | NIH grant | 1,064,953 | Reporter |
| 2025-07-16 | NIH grant | 177,500 | Reporter |
| 2025-07-15 | NIH grant | 142,000 | Reporter |
Showing 5 of 48 events.
Organization relationships (5)
Shown in this order: most evidence first.
| Related organization | Relationship | Evidence |
|---|---|---|
| Government of the United States of America | Co sponsors trial with | 2 |
| Boston University | Co sponsors trial with | 2 |
| Fogarty International Center of the National Institute of Health | Co sponsors trial with | 1 |
| Raymond Chiropractic | Co sponsors trial with | 1 |
| Institute of Population, Health and Development, Vietnam | Co sponsors trial with | 1 |
Latest dated events (75)
Shown in this order: newest first.
| Date | Event | Source |
|---|---|---|
| 2025-09-19 | NIH grant | Funding rounds and grants (NIH RePORTER + SEC EDGAR) |
| 2025-08-11 | NIH grant | Funding rounds and grants (NIH RePORTER + SEC EDGAR) |
| 2025-08-06 | NIH grant | Funding rounds and grants (NIH RePORTER + SEC EDGAR) |
| 2025-07-16 | NIH grant | Funding rounds and grants (NIH RePORTER + SEC EDGAR) |
| 2025-07-15 | NIH grant | Funding rounds and grants (NIH RePORTER + SEC EDGAR) |
Showing 5 of 75 events.
CLIA clinical laboratory certificates (2)
Shown in this order: active first, then certificate type.
| Lab | Certificate | Status |
|---|---|---|
| UNIVERSITY OF NEW ENGLAND | Certificate of compliance | Active |
| UNIVERSITY OF NEW ENGLAND | Certificate for PPM procedures | Active |
Biomarker capability evidence (6)
Shown in this order: tier desc, then gene symbol.
| Gene | Role | Evidence |
|---|---|---|
| CD4 | Trial sponsor | Named in trial inclusion criteria |
| SERPINF2 | Trial collaborator | Named in trial inclusion criteria |
| PTGS2 | Trial sponsor | Named in trial exclusion criteria |
| CD4 | Trial sponsor | Mentioned in trial text |
| PTGS2 | Trial sponsor | Mentioned in trial text |
Showing 5 of 6 evidence rows.
Biomarkers this organization publishes on (38)
Shown in this order: most publications first.
Showing 5 of 38 biomarkers.
Not on this page
Checked, with nothing recorded for this organization: companies grouped under this page, related companies not grouped here, active development programs, approved assets, sec-reported annual financials, fda warning letters, fda untitled letters, fda inspection record, fda recalls, fda import refusals, manufacturing and distribution sites, climate targets, as filed, and workforce and board diversity, as filed.